van Doorn PA[Author] - Search Results

Year	Number of Results
1987	2
1988	2
1989	1
1990	3
1991	2
1993	5
1994	2
1995	5
1996	5
1997	16
1998	5
1999	7
2000	13
2001	9
2002	11
2003	11
2004	14
2005	12
2006	19
2007	19
2008	15
2009	16
2010	20
2011	20
2012	17
2013	17
2014	14
2015	24
2016	23
2017	20
2018	11
2019	11
2020	10
2021	10

1

Guillain-Barré syndrome.

Willison HJ, Jacobs BC, van Doorn PA. Willison HJ, et al. Among authors: van doorn pa. Lancet. 2016 Aug 13;388(10045):717-27. doi: 10.1016/S0140-6736(16)00339-1. Epub 2016 Mar 2. Lancet. 2016. PMID: 26948435 Review.

2

Diagnosis and management of Guillain-Barré syndrome in ten steps.

Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Leonhard SE, et al. Among authors: van doorn pa. Nat Rev Neurol. 2019 Nov;15(11):671-683. doi: 10.1038/s41582-019-0250-9. Epub 2019 Sep 20. Nat Rev Neurol. 2019. PMID: 31541214 Free PMC article. Review.

3

Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. van den Berg B, et al. Among authors: van doorn pa. Nat Rev Neurol. 2014 Aug;10(8):469-82. doi: 10.1038/nrneurol.2014.121. Epub 2014 Jul 15. Nat Rev Neurol. 2014. PMID: 25023340 Review.

4

Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Bunschoten C, et al. Among authors: van doorn pa. Lancet Neurol. 2019 Aug;18(8):784-794. doi: 10.1016/S1474-4422(19)30144-9. Epub 2019 May 7. Lancet Neurol. 2019. PMID: 31076244 Review.

5

Treatment dilemmas in Guillain-Barré syndrome.

Verboon C, van Doorn PA, Jacobs BC. Verboon C, et al. Among authors: van doorn pa. J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):346-352. doi: 10.1136/jnnp-2016-314862. Epub 2016 Nov 11. J Neurol Neurosurg Psychiatry. 2017. PMID: 27837102 Review.

6

Intravenous immunoglobulin for Guillain-Barré syndrome.

Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: van doorn pa. Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD002063. doi: 10.1002/14651858.CD002063.pub6. Cochrane Database Syst Rev. 2014. PMID: 25238327 Free PMC article. Review.

7

Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).

van Doorn PA. van Doorn PA. Presse Med. 2013 Jun;42(6 Pt 2):e193-201. doi: 10.1016/j.lpm.2013.02.328. Epub 2013 Apr 28. Presse Med. 2013. PMID: 23628447 Review.

8

Peripheral neuropathies.

Hanewinckel R, Ikram MA, Van Doorn PA. Hanewinckel R, et al. Among authors: van doorn pa. Handb Clin Neurol. 2016;138:263-82. doi: 10.1016/B978-0-12-802973-2.00015-X. Handb Clin Neurol. 2016. PMID: 27637963 Review.

9

Corticosteroids for Guillain-Barré syndrome.

Hughes RA, Brassington R, Gunn AA, van Doorn PA. Hughes RA, et al. Among authors: van doorn pa. Cochrane Database Syst Rev. 2016 Oct 24;10(10):CD001446. doi: 10.1002/14651858.CD001446.pub5. Cochrane Database Syst Rev. 2016. PMID: 27775812 Free PMC article. Review.

10

Advances in management of Guillain-Barré syndrome.

Doets AY, Jacobs BC, van Doorn PA. Doets AY, et al. Among authors: van doorn pa. Curr Opin Neurol. 2018 Oct;31(5):541-550. doi: 10.1097/WCO.0000000000000602. Curr Opin Neurol. 2018. PMID: 30074496 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results